-1366x0.jpg)
GENTIS Confirms its Position with the Vietnam’s Number 1 Brand 2025 Award in Genetic Analysis - Gold Category
The Vietnam’s Number 1 Brand announcement ceremony is an annual program organized by the Asian Business Development Research Center. The event aims to encourage and honor businesses and entrepreneurs who have continuously strived, overcome market challenges, and made positive contributions to the community, thereby fostering the country’s economy in the new era - the Era of National Growth.
The awards are selected based on international quality standards for businesses with high-quality products and services. To be recognized for the award, products must meet strict criteria, including: being a leading brand in the industry; having products and services widely recognized by consumers; demonstrating sustainable development strategies; contributing to the economy; complying with environmental, tax, customs, intellectual property, and labor regulations; and demonstrating social and community responsibility.
In addition, depending on the industry sector, the selection committee will evaluate specific criteria: capabilities; management philosophy; technology and innovation activities; financial capacity; human resources; marketing strategies, etc. GENTIS excellently met these criteria and proudly received the Gold category “Vietnam’s Number 1 Brand 2025” award in the Genetic Analysis field.
Mr. Pham Dinh Minh (R&D Director of GENTIS) Receives the Gold Cup and Certificate for Vietnam’s Number 1 Brand 2025 in Genetic Analysis
This award is a testament to the quality of GENTIS’s tests on the market and the trust and loyalty of its customers towards the GENTIS brand. It also serves as motivation for the company to continue delivering even more value to its partners and customers.
Looking at its development journey, it is evident that GENTIS has always been at the forefront of making new advancements in applying technology and building a comprehensive genetic testing ecosystem that caters to a wide range of customers. GENTIS’s product and service ecosystem continues to expand and diversify, including services for assisted reproduction, obstetrics and gynecology, andrology, hematology - immunology, oncology - pediatrics, and family testing.
Furthermore, to increase partner and customer satisfaction, GENTIS consistently focuses on improving and optimizing the testing process to save costs for patients. GENTIS also strengthens training efforts to improve the professional skills, knowledge, and expertise of its staff to meet the increasing demands of the job.
GENTIS understands that customer satisfaction comes not only from good products and services but also from comprehensive, attentive care experiences. GENTIS will continue to strive to bring more value to the community.
GENTIS Awarded Vietnam’s Number 1 Brand 2025 in Genetic Analysis - Gold Category
PGT-Max 1 Test - A Technological Breakthrough in Pre-implantation Genetic Testing
At the Vietnam’s Number 1 Brand 2025 announcement ceremony, GENTIS’s PGT-Max 1 test was honored in the “Best Medical Product/Service for Consumers” category. This is a significant milestone for GENTIS in asserting the quality of the PGT-Max 1 test.
According to experts, genetic disorders in assisted reproduction are increasingly on the rise. One method to detect genetic abnormalities in embryos is Pre-implantation Genetic Testing for Aneuploidy (PGT-Max 1). PGT-Max 1 is a pre-implantation genetic test that helps select embryos without chromosomal abnormalities (24 chromosomes), without additional mutations, or chromosomal segment deletions, optimizing the embryo selection process before IVF (in vitro fertilization), ensuring that the child born is healthy and free of the genetic abnormalities detected.
GENTIS’s PGT-Max 1 Test Recognized as the Best Medical Product/Service for Consumers in 2025
GENTIS has successfully optimized and applied the PGT-Max 1 test on embryos for many infertile couples hoping for a child. Thanks to the PGT-Max 1 test, doctors and experts can select embryos with good genetic quality, increasing the chances of successful implantation during IVF, ensuring that the child is born healthy and free from the genetic abnormalities screened.
At GENTIS, the PGT-Max 1 test is performed using advanced technologies, including NGS sequencers from Illumina (USA) and specialized bioinformatics software, with the highest sensitivity and specificity of up to 99.9%. GENTIS will also continue to strive to develop and deliver the most advanced and safest genetic testing solutions as part of its mission to enhance the physical and intellectual well-being of the Vietnamese people.
The Vietnam’s Number 1 Brand 2025 award in Genetic Analysis and the Best Medical Product/Service for Consumers in 2025 for the PGT-Max 1 test marks a milestone acknowledging GENTIS’s contributions. This will serve as motivation for GENTIS to continue its mission to “enhance the intellect and health of the Vietnamese people” in the future.
